Metabolic CCl4
SEEK ID: https://seek.lisym.org/assays/8
Experimental assay
Projects: Chronic Liver Disease Progression (LiSyM-DP - Pillar II)
Investigation: Julia/Yan
Study: CCl4 Treatment in mice
Assay type: Proteomics
Technology type: FACS
Organisms: Mus musculus
Export PNG
Download
Contributor and Creators
Views: 1779
Created: 21st Nov 2017 at 15:02
Last updated: 28th Dec 2017 at 13:43
Related items
Projects: Chronic Liver Disease Progression (LiSyM-DP - Pillar II), Regeneration and Repair in Acute-on-Chronic Liver Failure (LiSyM-ACLF - Pillar III), LiSyM network, LiSyM PALs, LiSyM-Krebs Partnering
Institutions: Molecular Hepatology - Dept of Medicine II - Medical Faculty Mannheim - Heidelberg University
Chronic liver diseases (CLD) progression leads to cirrhosis, often cancer, and ultimately to organ failure and death. Because of the complexity of this scenario, a Systems Medicine approach is chosen to develop strategies to better characterize progression and resolution of fibrosis. Pillar II aims to define key molecular mechanisms and structural changes in tissue architecture during the progression of CLD by visualizing and quantifying at a cellular level, tissue and organ scale.
Public web page: Not specified
Pillar II dooley
Snapshots: No snapshots
RNA microarray made with primary hepatocytes from female mice with hepatocyte-specific, embryonic knockout of Smoothened
This SOP - Standard Operating Procedure for Sample Collection and Preservation of Blood and
Endometrial Tissue were developed at NIH University of California San Francisco Human Endometrial Tissue and DNA Bank
by Elizabeth Sheldonand, Ramsey A McIntire
Creators: Olga Krebs, Martin Golebiewski, Elizabeth Sheldonand, Ramsey A McIntire
Contributor: Olga Krebs
